DCF — TEXAS INSTITUTE FOR SURGERY AT PRES
Enterprise Value: $48.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$48.7M
Enterprise Value
$12.4M
PV of Cash Flows
$36.3M
PV of Terminal Value
$58.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $78.8M | $6.7M | 8.0% | $2.2M | $2.0M |
| Year 2 | $81.1M | $7.7M | 9.0% | $2.9M | $2.4M |
| Year 3 | $83.6M | $8.8M | 10.0% | $3.6M | $2.7M |
| Year 4 | $86.1M | $9.5M | 11.0% | $4.0M | $2.7M |
| Year 5 | $88.7M | $10.0M | 11.0% | $4.3M | $2.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $48.7M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$76.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0799999937244345
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5